Transient Tachypnea of the Newborn A Comprehensive Review with Indian Perspectives on Epidemiology, Pathophysiology, and Management
1. Aditi Upadhyay
2. Sakshi
3. Khan Mohd Kazim
4. Kajal Khan
5. Muktarali kyzy Begimai
(1. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
2. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
3. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
4. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
5. Teacher, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic.)
Abstract
Transient tachypnea of the newborn (TTN) represents the most common cause of respiratory distress in late preterm and term neonates, arising from delayed clearance of fetal lung fluid following the transition to extrauterine life. This self-limiting condition, while generally benign, accounts for substantial neonatal intensive care unit admissions, maternal-infant separation, and healthcare resource utilization, particularly in countries with rising cesarean delivery rates such as India. This review examines the contemporary understanding of TTN, integrating recent advances in pathophysiological mechanisms, diagnostic methodologies, and evidence-based management strategies, with particular attention to the Indian context where the condition affects a significant proportion of newborns. A comprehensive literature search was conducted focusing on publications from 2017 to 2025, with emphasis on studies from the Indian subcontinent and international guidelines. The analysis reveals that TTN results from impaired absorption of fetal lung fluid due to insufficient catecholamine stimulation, particularly in infants delivered by cesarean section without labor. Risk factors include cesarean delivery, late preterm gestation, male sex, maternal diabetes, and maternal asthma. Diagnosis remains primarily clinical, supported by characteristic chest radiographic findings and increasingly by lung ultrasound, which offers a radiation-free alternative with excellent diagnostic accuracy. Management is predominantly supportive, with supplemental oxygen and non-invasive respiratory support as needed, while pharmacological interventions including salbutamol and corticosteroids remain controversial. The rising cesarean delivery rates in India, with urban rates exceeding 30% in many regions, have contributed to increased TTN incidence, with studies reporting rates of 16 to 46.6 per 1000 live births in tertiary care settings. Prevention strategies focusing on reducing unnecessary cesarean deliveries and optimizing timing of elective procedures offer the most promising avenues for reducing TTN burden. While the prognosis is generally excellent with resolution within 24 to 72 hours, emerging evidence suggests associations with childhood wheezing disorders, warranting longitudinal follow-up of affected infants.
Introduction
The first breath of a newborn represents one of the most profound physiological transitions in human life, as the fluid-filled lungs of the fetus must transform within moments into organs capable of efficient gas exchange. This transformation requires the rapid clearance of fetal lung fluid, the establishment of functional residual capacity, and the initiation of rhythmic breathing movements coordinated with pulmonary blood flow. For most infants, this transition unfolds seamlessly; for others, particularly those born by cesarean section without the benefit of labor, the process is delayed, resulting in a condition that has been recognized for over a century yet continues to challenge clinicians worldwide.
Transient tachypnea of the newborn, first described by Mary Ellen Avery and Orville Grady in 1966 as "transient respiratory distress of the newborn," represents the most common cause of respiratory distress in late preterm and term infants. The condition arises from delayed clearance of fetal lung fluid, leading to decreased pulmonary compliance, impaired gas exchange, and the characteristic clinical picture of tachypnea, mild retractions, and occasional grunting. While generally benign and self-limiting, TTN accounts for substantial neonatal intensive care unit admissions, separates mothers from their infants during a critical bonding period, and generates considerable anxiety for families and healthcare providers alike.
The global epidemiology of TTN has been dramatically shaped by the rising rates of cesarean delivery, which has emerged as the single most important modifiable risk factor. In India, where the cesarean delivery rate has risen from approximately 5% in rural areas and 18% in urban areas two decades ago to over 30% in many tertiary care centers today, the burden of TTN has correspondingly increased. Studies from across India report TTN incidence ranging from 13 to 46.6 per 1000 live births, substantially higher than rates reported from Western countries, reflecting both the high cesarean delivery rates and the referral patterns of tertiary care institutions.
The pathophysiology of TTN, while conceptually straightforward, involves complex interactions between hormonal signaling, epithelial ion transport, and mechanical forces that clear fetal lung fluid in preparation for air breathing. The absence of labor in cesarean deliveries deprives the infant of the catecholamine surge that normally activates sodium channels in the alveolar epithelium, thereby impairing fluid absorption. This understanding has informed prevention strategies, including the administration of antenatal corticosteroids before elective cesarean delivery and efforts to reduce unnecessary cesarean sections.
The clinical management of TTN has evolved considerably, with increasing emphasis on non-invasive respiratory support, careful monitoring, and avoidance of unnecessary interventions. The recognition that TTN is generally self-limiting has prompted efforts to reduce antibiotic exposure, shorten hospital stays, and support family-centered care. However, the condition must be carefully distinguished from more serious causes of respiratory distress, including respiratory distress syndrome, pneumonia, and sepsis, which require specific interventions.
This review aims to provide a comprehensive examination of transient tachypnea of the newborn, encompassing the underlying pathophysiological mechanisms, epidemiological patterns with particular attention to the Indian context, clinical manifestations, diagnostic approaches, management strategies, and prevention efforts. Through this synthesis, we seek to illuminate both the considerable progress made in understanding and managing this common condition and the persistent challenges that remain in optimizing care for affected infants and their families.
Methods
A comprehensive literature search was conducted to identify relevant publications addressing transient tachypnea of the newborn, with particular emphasis on studies from India and contemporary management guidelines. The search encompassed databases including PubMed, MEDLINE, and the Cochrane Library, with primary focus on literature published between January 2017 and October 2025 to ensure inclusion of contemporary evidence and emerging trends. Search terms incorporated "transient tachypnea of newborn," "TTN," "neonatal respiratory distress," "fetal lung fluid," "cesarean delivery," "India," "lung ultrasound," "salbutamol," and "antenatal corticosteroids."
Inclusion criteria prioritized original research articles, systematic reviews, meta-analyses, clinical practice guidelines, and cohort studies specifically addressing TTN in newborn infants or containing substantial neonatal subgroups. The methodological framework emphasized evidence-based guidelines including the European Consensus Guidelines on the Management of Respiratory Distress Syndrome, the American Academy of Pediatrics recommendations, and studies from major Indian institutions including the All India Institute of Medical Sciences, King George's Medical University, and various regional tertiary care centers. Particular attention was directed toward studies comparing diagnostic modalities, evaluating pharmacological interventions, and examining risk factors in Indian populations.
The analysis synthesized data from multiple study designs, acknowledging the inherent challenges of neonatal research including ethical constraints on randomized trials, the difficulty of blinding interventions involving visible treatments, and the variability in diagnostic criteria across studies. Where evidence specific to TTN was limited, findings from studies of neonatal respiratory distress generally were extrapolated with appropriate caveats.
Results
Pathophysiology
The fundamental abnormality in transient tachypnea of the newborn is the delayed clearance of fetal lung fluid, which normally occupies the potential airspaces of the developing lung and is essential for normal lung growth and development. This fluid is secreted by the pulmonary epithelium throughout gestation, with production decreasing in the days preceding labor as the lung prepares for the transition to air breathing. The clearance of this fluid at birth occurs through multiple mechanisms, including mechanical expulsion during vaginal delivery, absorption into the pulmonary circulation and lymphatics, and active sodium transport across the alveolar epithelium.
The active transport of sodium represents the critical final pathway in lung fluid clearance. During labor, the surge in catecholamines, particularly epinephrine, stimulates the transformation of the pulmonary epithelium from a secretory to an absorptive phenotype. This transformation involves the activation of amiloride-sensitive epithelial sodium channels (ENaC) on the apical surface of alveolar type II cells, which transport sodium from the airspaces into the cells. The sodium is then extruded across the basolateral membrane by the sodium-potassium ATPase, creating an osmotic gradient that drives water reabsorption. Additionally, the opening of potassium channels and the activation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels contribute to the coordinated ion transport that facilitates fluid clearance.
In infants delivered by cesarean section without labor, the catecholamine surge is attenuated or absent, resulting in impaired activation of sodium channels and delayed fluid clearance. The residual fluid in the alveoli and interstitium increases lung water content, decreases pulmonary compliance, and impairs gas exchange, leading to the clinical manifestations of TTN. The "vaginal squeeze" during vaginal delivery, once thought to be the primary mechanism of fluid expulsion, accounts for only a small fraction of fluid clearance, explaining why even vaginally delivered infants can develop TTN when other mechanisms are impaired.
The hormonal regulation of lung fluid clearance involves not only catecholamines but also glucocorticoids, thyroid hormones, and arginine vasopressin. Antenatal corticosteroids accelerate lung maturation and enhance the expression of sodium channels, which explains their protective effect against TTN when administered before elective cesarean delivery. Thyroid hormones increase the number and activity of sodium-potassium ATPase pumps, while arginine vasopressin may inhibit fluid secretion and promote absorption.
Recent research has identified additional factors influencing lung fluid clearance, including genetic polymorphisms in genes encoding ion transport proteins, maternal vitamin D status, and maternal intrahepatic cholestasis. Lower maternal and infant vitamin D levels have been associated with increased TTN risk, possibly through effects on epithelial sodium channel expression. Maternal intrahepatic cholestasis, characterized by elevated bile acids, has similarly been linked to higher TTN incidence, though the mechanisms remain incompletely understood.
Epidemiology and Risk Factors
Transient tachypnea of the newborn is the most common cause of respiratory distress in late preterm and term infants, with reported incidence varying widely depending on gestational age, mode of delivery, and study population. Globally, TTN affects approximately 1% to 2% of all live births, though rates as high as 7% to 10% have been reported in certain high-risk populations. The incidence is inversely proportional to gestational age, affecting approximately 10% of infants born at 33 to 34 weeks, 5% of those born at 35 to 36 weeks, and less than 1% of those born at 37 weeks or later. Despite this gradient, most cases occur in term infants simply because term births numerically predominate.
In India, the epidemiology of TTN reflects the country's rising cesarean delivery rates and the referral patterns of tertiary care institutions. A landmark study by Kumar and Bhat published in 1996 examined 4505 newborns over 13 months and found that TTN was the commonest cause of respiratory distress, accounting for 42.7% of cases. More recent studies have confirmed this predominance, with a 2022 study from a tertiary care center in Western India reporting an incidence of 16 per 1000 live births, with TTN accounting for 39% of respiratory distress in term and late preterm infants. Unpublished data from the All India Institute of Medical Sciences (AIIMS) over five years (2010-2016) reported an even higher incidence of 46.6 per 1000 live births, reflecting the referral of high-risk pregnancies and the high cesarean delivery rates at this apex institution.
The cesarean delivery rate in India has risen dramatically over the past two decades, from approximately 5% in rural areas and 18% in urban areas in the early 2000s to over 30% in many tertiary care centers today. This increase has been driven by multiple factors, including changing obstetric practices, patient preferences, medicolegal concerns, and the increasing proportion of institutional deliveries. The relationship between cesarean delivery and TTN is well established, with studies demonstrating a two- to three-fold increase in TTN risk among infants delivered by elective cesarean section compared to those born vaginally. In the Western Indian study, 70.3% of TTN cases were born by lower segment cesarean section (LSCS), and cesarean delivery was associated with longer duration of tachypnea compared to vaginal delivery.
Beyond cesarean delivery, multiple risk factors for TTN have been identified. Late preterm gestation (34 to 36 6/7 weeks) confers substantially increased risk due to immaturity of the mechanisms involved in lung fluid clearance. Male sex has been consistently identified as a risk factor, with male infants comprising approximately 60% to 65% of TTN cases in most series, possibly reflecting differences in lung growth and maturation between sexes. Maternal diabetes mellitus, both pregestational and gestational, increases TTN risk through mechanisms that may involve delayed surfactant production and impaired fluid clearance. Maternal asthma has also been associated with increased TTN risk, potentially through effects on fetal lung development or shared genetic predisposition.
Additional risk factors include small or large size for gestational age, perinatal asphyxia, maternal obesity, and multiple gestation. The interaction between gestational age and mode of delivery is particularly important, with the risk of TTN being substantially higher for late preterm infants delivered by cesarean section than for term infants delivered vaginally. This interaction has focused attention on the categories of "late preterm" and "early term" infants, who may be particularly vulnerable to respiratory complications.
Clinical Manifestations
The clinical presentation of transient tachypnea of the newborn is characterized by the onset of respiratory distress within the first two hours of life, typically in an infant with one or more established risk factors. Tachypnea, defined as a respiratory rate exceeding 60 breaths per minute, is the hallmark finding and may be accompanied by mild to moderate subcostal and intercostal retractions, nasal flaring, and occasional expiratory grunting. The severity of respiratory distress in TTN is generally less than in other neonatal respiratory disorders, and significant hypoxemia is uncommon, though mild cyanosis may occur and typically responds to supplemental oxygen.
Auscultation may reveal clear or slightly decreased breath sounds, but rales and wheezing are generally absent, helping to distinguish TTN from pneumonia or other parenchymal lung diseases. The infant's general appearance is usually reassuring, with normal activity and feeding behavior once the respiratory rate stabilizes. Importantly, infants with TTN typically lack signs of sepsis such as temperature instability, lethargy, or poor perfusion, though the distinction from early-onset sepsis can be challenging in the first hours of life.
The natural history of TTN is characterized by gradual resolution over 24 to 72 hours, with most infants showing significant improvement within the first 24 to 48 hours. In the Western Indian study, tachypnea resolved within 24 hours in 81.8% of vaginally delivered infants but only 44.2% of those delivered by cesarean section, with the mean duration being 26.2 hours for vaginal delivery versus 32.4 hours for cesarean delivery. Low birth weight and prematurity were associated with longer duration of distress, with low birth weight infants requiring a mean of 38.9 hours for resolution compared to 26.3 hours for normal birth weight infants.
While TTN is generally benign, severe complications have been reported, though they are rare. These include persistent pulmonary hypertension of the newborn, air leak syndromes, and prolonged tachypnea requiring extended respiratory support. The development of such complications should prompt reconsideration of the diagnosis and evaluation for alternative or additional pathologies.
Diagnosis
The diagnosis of transient tachypnea of the newborn is primarily clinical, based on the characteristic presentation of respiratory distress in an infant with known risk factors, particularly cesarean delivery or late preterm gestation. The diagnosis is supported by the exclusion of more serious conditions such as respiratory distress syndrome, pneumonia, sepsis, and congenital heart disease. The distinction from "delayed transition," a brief period of respiratory distress in the immediate postnatal period that resolves within six hours without intervention, is important, as TTN is defined by symptoms persisting beyond this period.
Chest radiography remains the standard imaging modality for confirming the diagnosis and excluding alternative pathologies. The characteristic radiographic findings of TTN include prominent vascular markings, fluid in the interlobar fissures, hyperinflation with flattened diaphragms, and a "wet silhouette" around the heart. These findings reflect the increased lung water content and interstitial fluid accumulation that characterize the condition. The radiographic appearance can sometimes be difficult to distinguish from early respiratory distress syndrome or pneumonia, particularly in preterm infants, and serial films may be necessary if the clinical course is atypical.
Lung ultrasound has emerged as a valuable diagnostic tool for TTN, offering several advantages over chest radiography, including the absence of ionizing radiation, bedside availability, and the ability to perform serial examinations. The characteristic lung ultrasound findings in TTN include B-lines (vertical artifacts arising from the pleural line), pleural line abnormalities, and the absence of lung consolidation. Studies have demonstrated that lung ultrasound can accurately differentiate TTN from respiratory distress syndrome, pneumonia, and other causes of respiratory distress, with sensitivity and specificity exceeding 90% in experienced hands. The technique is particularly valuable in resource-limited settings where chest radiography may be unavailable or where radiation exposure is a concern.
Laboratory investigations in TTN are generally nonspecific and primarily serve to exclude alternative diagnoses. Arterial blood gas analysis may reveal mild hypoxemia and respiratory acidosis, but significant metabolic acidosis or severe hypoxemia should prompt consideration of alternative diagnoses. Complete blood count and inflammatory markers are typically normal, helping to distinguish TTN from infectious processes. Blood cultures should be obtained when sepsis is suspected, though the decision to initiate antibiotics should be based on the overall clinical assessment rather than isolated laboratory findings.
Management
The management of transient tachypnea of the newborn is predominantly supportive, with the primary goals being to maintain adequate oxygenation, ensure nutritional support, and monitor for complications or alternative diagnoses. Most infants with TTN require only supplemental oxygen, which can be delivered via nasal cannula, hood, or head box, depending on the severity of hypoxemia and the resources available. The fraction of inspired oxygen should be titrated to maintain oxygen saturation within the target range, typically 90% to 95% for term infants and 88% to 92% for preterm infants.
Non-invasive respiratory support, including continuous positive airway pressure (CPAP) and high-flow nasal cannula, may be beneficial for infants with more significant respiratory distress or hypoxemia. CPAP helps maintain functional residual capacity, improves oxygenation, and may accelerate the clearance of lung fluid by applying positive pressure throughout the respiratory cycle. However, most infants with TTN do not require such support, and the decision to escalate therapy should be based on objective criteria including oxygen requirement, work of breathing, and blood gas abnormalities.
Nutritional support is an important aspect of management, as tachypnea increases the risk of aspiration and may impair feeding. Infants with significant tachypnea may require gavage feeding or intravenous fluids until the respiratory rate stabilizes. Breastfeeding should be encouraged when the infant's respiratory rate permits safe feeding, as breast milk provides optimal nutrition and immunological protection.
Pharmacological interventions for TTN have been extensively studied, with mixed results. Salbutamol, a beta-agonist that stimulates sodium channel activity and promotes lung fluid clearance, has been evaluated in multiple randomized controlled trials. A 2021 Cochrane review concluded that salbutamol may slightly reduce the duration of tachypnea and hospital stay, but the certainty of evidence was low, and the clinical significance of these modest effects was uncertain. Diuretics such as furosemide have not been shown to benefit infants with TTN and may cause electrolyte disturbances, and their use is not recommended. Inhaled corticosteroids have been evaluated in small trials with some suggestion of benefit, but the evidence is insufficient to support routine use.
Antibiotic therapy is not indicated for TTN itself, but many infants receive empiric antibiotics because of the difficulty in distinguishing TTN from pneumonia or sepsis in the early neonatal period. Efforts to reduce unnecessary antibiotic exposure include careful clinical assessment, the use of biomarkers such as C-reactive protein and procalcitonin, and the implementation of antibiotic stewardship programs. In the Western Indian study, none of the 74 infants with TTN required ventilatory support, and all recovered without complications, supporting a conservative approach to management.
Prevention
The most effective strategy for preventing transient tachypnea of the newborn is the reduction of unnecessary cesarean deliveries, particularly those performed without medical indication before 39 weeks of gestation. The American College of Obstetricians and Gynecologists recommends avoiding elective cesarean delivery before 39 weeks unless medically indicated, and similar recommendations have been made by professional organizations worldwide. In India, where cesarean delivery rates continue to rise, efforts to promote vaginal birth after cesarean, reduce primary cesarean deliveries, and educate healthcare providers and patients about the risks of unnecessary cesarean delivery are essential.
For cesarean deliveries that are medically necessary before 39 weeks, the administration of antenatal corticosteroids has been shown to reduce the risk of TTN and other respiratory complications. The mechanism involves acceleration of lung maturation and enhanced expression of sodium channels involved in fluid clearance. However, the optimal timing and dosing of antenatal corticosteroids for this indication remain subjects of investigation, and the practice has not been universally adopted.
The optimization of maternal health, including glycemic control in diabetic mothers and management of maternal asthma, may reduce the risk of TTN. Additionally, the avoidance of elective cesarean delivery in late preterm and early term infants when vaginal delivery is safe should be emphasized, as these gestational ages carry the highest risk of TTN.
Indian Context and Public Health Implications
The burden of transient tachypnea of the newborn in India reflects the broader challenges of maternal and child health in a country undergoing rapid demographic and epidemiological transitions. The rising cesarean delivery rate, driven by medical, social, and economic factors, has contributed to increased TTN incidence, with studies from tertiary care centers reporting rates substantially higher than those from Western countries. This increase has important implications for neonatal intensive care unit capacity, healthcare costs, and family well-being.
The concentration of TTN cases in tertiary care centers reflects both the referral of high-risk pregnancies and the concentration of cesarean deliveries in these institutions. In many Indian hospitals, the cesarean delivery rate exceeds 40%, with elective procedures performed for non-medical reasons contributing significantly to the total. The financial incentives associated with cesarean delivery, the convenience of scheduled procedures, and the perceived safety of surgical delivery have all contributed to this trend, despite the known risks to both mother and infant.
The management of TTN in Indian settings is generally consistent with international guidelines, with supportive care forming the mainstay of treatment. However, resource limitations in many settings affect the availability of non-invasive respiratory support, monitoring equipment, and trained personnel. The use of lung ultrasound, while promising, is limited by the availability of trained sonographers and appropriate equipment. The development of low-cost, portable ultrasound devices and training programs for neonatal providers could expand access to this valuable diagnostic tool.
The psychosocial impact of TTN on Indian families deserves attention. The separation of mother and infant during the NICU admission can disrupt breastfeeding, delay bonding, and generate considerable anxiety. In a cultural context where the birth of a child is celebrated with extended family involvement, the admission of an infant to the NICU can be particularly distressing. Family-centered care practices, including kangaroo mother care, rooming-in when feasible, and clear communication with parents, can help mitigate these effects.
Long-term Outcomes
While transient tachypnea of the newborn is generally considered a benign, self-limiting condition, emerging evidence suggests that affected infants may face increased risks of respiratory morbidity later in childhood. Several studies have reported associations between TTN and subsequent wheezing disorders, asthma, and atopy, though the mechanisms underlying these associations remain incompletely understood. Possible explanations include shared genetic predisposition, epigenetic modifications induced by the neonatal respiratory insult, or persistent alterations in lung structure or function.
The evidence regarding long-term outcomes is limited by the lack of large, well-designed cohort studies with extended follow-up. Most existing studies are retrospective and subject to confounding by indication, as infants with TTN differ from unaffected infants in multiple respects, including mode of delivery and gestational age. Nevertheless, the consistency of the association across multiple studies suggests that TTN may not be entirely without long-term consequences.
For clinical practice, these findings suggest that infants with TTN may benefit from longitudinal follow-up to monitor for respiratory symptoms, particularly wheezing, and that parents should be counseled about the possible increased risk of asthma. However, the absolute risk remains modest, and most children with a history of TTN will not develop significant respiratory disease.
Discussion
The contemporary understanding of transient tachypnea of the newborn has advanced considerably since its initial description, yet the condition remains a significant contributor to neonatal morbidity and healthcare resource utilization, particularly in countries with high cesarean delivery rates such as India. The pathophysiological basis of TTN—delayed clearance of fetal lung fluid due to insufficient catecholamine stimulation—is well established, and this understanding has informed both preventive strategies and therapeutic interventions.
The rising cesarean delivery rate in India represents a complex public health challenge with implications extending far beyond TTN. While cesarean delivery can be life-saving for both mother and infant in certain circumstances, the increasing performance of the procedure without medical indication has contributed to increased maternal morbidity, neonatal respiratory complications, and healthcare costs. Addressing this trend requires multifaceted interventions, including provider education, patient counseling, financial disincentives for unnecessary cesarean delivery, and quality improvement initiatives to promote appropriate obstetric care.
The diagnostic evaluation of TTN has been enhanced by the advent of lung ultrasound, which offers a radiation-free, bedside alternative to chest radiography with excellent diagnostic accuracy. However, the implementation of lung ultrasound in routine clinical practice requires appropriate training and quality assurance, particularly in resource-limited settings. The development of standardized protocols and training programs could facilitate wider adoption of this valuable tool.
The management of TTN remains predominantly supportive, with no pharmacological intervention demonstrating clear, clinically significant benefit. The use of salbutamol and other beta-agonists remains controversial, with modest effects on duration of symptoms but insufficient evidence to support routine use. Similarly, diuretics are not recommended, and corticosteroids require further evaluation. The emphasis on supportive care reflects the self-limiting nature of the condition and the importance of avoiding unnecessary interventions that may cause harm.
The prevention of TTN through reduction of unnecessary cesarean deliveries and optimization of the timing of elective procedures represents the most promising approach to reducing the burden of this condition. Antenatal corticosteroids before elective cesarean delivery have shown promise, but their use must be balanced against potential risks, and further research is needed to define optimal protocols.
The long-term implications of TTN, particularly the possible association with childhood wheezing disorders, warrant further investigation through prospective cohort studies with extended follow-up. Such studies should control for confounding factors and examine potential mechanisms linking neonatal respiratory distress to later respiratory morbidity.
Conclusion
Transient tachypnea of the newborn remains the most common cause of respiratory distress in late preterm and term infants, with particular significance in India where rising cesarean delivery rates have contributed to increased incidence. The condition arises from delayed clearance of fetal lung fluid due to insufficient catecholamine stimulation, particularly in infants delivered by cesarean section without labor. While generally benign and self-limiting, TTN accounts for substantial neonatal intensive care unit admissions, maternal-infant separation, and healthcare resource utilization.
The management of TTN is predominantly supportive, with supplemental oxygen and non-invasive respiratory support as needed, while pharmacological interventions remain controversial. The prevention of TTN through reduction of unnecessary cesarean deliveries, optimization of the timing of elective procedures, and administration of antenatal corticosteroids when indicated offers the most promising approach to reducing the burden of this condition. Lung ultrasound has emerged as a valuable diagnostic tool, offering a radiation-free alternative to chest radiography with excellent diagnostic accuracy.
While the prognosis for infants with TTN is generally excellent, emerging evidence suggests possible associations with childhood wheezing disorders, warranting longitudinal follow-up of affected infants. As India continues to grapple with the challenges of rising cesarean delivery rates and their consequences, the prevention and optimal management of TTN will remain important priorities for maternal and child health.
References
Kumar A, Bhat BV. Epidemiology of respiratory distress of newborns. Indian J Pediatr. 1996;63(1):93-98.
Incidence, Clinical Features, and Outcomes of Transient Tachypnea of the Newborn at a Tertiary Care Center in Western India. Cureus. 2022;14(4):e23907.
Alhassen Z, Vali P, Nair J, et al. Recent Advances in Pathophysiology and Management of Transient Tachypnea of Newborn. J Perinatol. 2021;41(1):6-16.
Bruschettini M, Hassan KO, Romantsik O, Banzi R, Calevo MG, Moresco L. Interventions for the management of transient tachypnoea of the newborn - an overview of systematic reviews. Cochrane Database Syst Rev. 2022;2(2):CD013563.
Moresco L, Bruschettini M, Macchi M, Calevo MG. Salbutamol for transient tachypnea of the newborn. Cochrane Database Syst Rev. 2021;2(2):CD011878.
Transient Tachypnea of the Newborn. StatPearls. Treasure Island (FL): StatPearls Publishing; 2026.
Transient tachypnoea: new concepts on the commonest neonatal respiratory disorder. Eur Respir Rev. 2025;34(175):240112.
Hermansen CL, Lorah KN. Respiratory distress in the newborn. Am Fam Physician. 2007;76(7):987-994.
Risk Factors of Respiratory Diseases Among Neonates in Neonatal Intensive Care Unit of Qena University Hospital, Egypt. Ann Glob Health. 2020;86(1):14.
Prevalence and etiology of respiratory distress in newborns. Pak Armed Forces Med J. 2013;63(1):22-25.
Hagen E, Chu A, Lew C. Transient tachypnea of the newborn. NeoReviews. 2017;18(3):e139-e148.
Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics. 2006;118(3):1207-1214.
Riskin A, Abend-Weinger M, Riskin-Mashiah S, Kugelman A, Bader D. Cesarean section, gestational age, and transient tachypnea of the newborn: timing is the key. Am J Perinatol. 2005;22(7):377-382.
Liem JJ, Huq SI, Ekuma O, Becker AB, Kozyrskyj AL. Transient tachypnea of the newborn may be an early clinical manifestation of wheezing symptoms. J Pediatr. 2007;151(1):29-33.
Kweon S, Chung JH, Kim MY, et al. Clinical characteristics and outcome of transient tachypnea of the newborn in late preterm and term infants. J Korean Med Sci. 2014;29(12):1669-1673.
Dani C, Reali MF, Bertini G, et al. Risk factors for the development of respiratory distress syndrome and transient tachypnea in newborn infants. Eur J Pediatr. 1999;158(11):903-908.
Badran EF, Abdalgani MM, Al-Hadidi MS, et al. Risk factors of transient tachypnea of the newborn. Saudi Med J. 2012;33(1):37-40.
Kasap B, Duman N, Ozer E, et al. Transient tachypnea of the newborn: predictive factor for duration of tachypnea. Pediatr Int. 2008;50(1):81-84.
Tutdibi E, Gries K, Bücheler M, et al. Impact of labor on outcomes in transient tachypnea of the newborn: population-based study. Pediatrics. 2010;125(3):e577-e583.
Vaisbourd Y, Abu-Raya B, Zangen S, et al. Inhaled corticosteroids in transient tachypnea of the newborn: a randomized, placebo-controlled study. Pediatr Pulmonol. 2017;52(8):1043-1050.